281 related articles for article (PubMed ID: 21038470)
1. Acquisition of regulatory function by human CD8(+) T cells treated with anti-CD3 antibody requires TNF.
Ablamunits V; Bisikirska B; Herold KC
Eur J Immunol; 2010 Oct; 40(10):2891-901. PubMed ID: 21038470
[TBL] [Abstract][Full Text] [Related]
2. TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs.
Bisikirska B; Colgan J; Luban J; Bluestone JA; Herold KC
J Clin Invest; 2005 Oct; 115(10):2904-13. PubMed ID: 16167085
[TBL] [Abstract][Full Text] [Related]
3. CD8 blockade promotes the expansion of antigen-specific CD4+ FOXP3+ regulatory T cells in vivo.
Wang Z; Davies JD
Int Immunopharmacol; 2007 Feb; 7(2):249-65. PubMed ID: 17178393
[TBL] [Abstract][Full Text] [Related]
4. Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signals.
Mitsui J; Nishikawa H; Muraoka D; Wang L; Noguchi T; Sato E; Kondo S; Allison JP; Sakaguchi S; Old LJ; Kato T; Shiku H
Clin Cancer Res; 2010 May; 16(10):2781-91. PubMed ID: 20460483
[TBL] [Abstract][Full Text] [Related]
5. Adult T-cell leukemia/lymphoma cells from blood and skin tumors express cytotoxic T lymphocyte-associated antigen-4 and Foxp3 but lack suppressor activity toward autologous CD8+ T cells.
Shimauchi T; Kabashima K; Tokura Y
Cancer Sci; 2008 Jan; 99(1):98-106. PubMed ID: 17970785
[TBL] [Abstract][Full Text] [Related]
6. Remodeling T cell compartments during anti-CD3 immunotherapy of type 1 diabetes.
Long SA; Thorpe J; Herold KC; Ehlers M; Sanda S; Lim N; Linsley PS; Nepom GT; Harris KM
Cell Immunol; 2017 Sep; 319():3-9. PubMed ID: 28844471
[TBL] [Abstract][Full Text] [Related]
7. Follicular lymphoma intratumoral CD4+CD25+GITR+ regulatory T cells potently suppress CD3/CD28-costimulated autologous and allogeneic CD8+CD25- and CD4+CD25- T cells.
Hilchey SP; De A; Rimsza LM; Bankert RB; Bernstein SH
J Immunol; 2007 Apr; 178(7):4051-61. PubMed ID: 17371959
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 binding to CD4 on CD4+CD25+ regulatory T cells enhances their suppressive function and induces them to home to, and accumulate in, peripheral and mucosal lymphoid tissues: an additional mechanism of immunosuppression.
Ji J; Cloyd MW
Int Immunol; 2009 Mar; 21(3):283-94. PubMed ID: 19208751
[TBL] [Abstract][Full Text] [Related]
9. NKG2A is a marker for acquisition of regulatory function by human CD8+ T cells activated with anti-CD3 antibody.
Ablamunits V; Henegariu O; Preston-Hurlburt P; Herold KC
Eur J Immunol; 2011 Jul; 41(7):1832-42. PubMed ID: 21538351
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of Foxp3+ CD4+ CD25+ regulatory cells in peripheral blood of patients with SLE].
Wei HG; Cai B; Wang LL; Li J; Feng WH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 May; 23(5):432-5. PubMed ID: 17488604
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of antigen-specific CD8 T cells in patients with type 1 diabetes treated with antiCD3 monoclonal antibodies.
Cernea S; Herold KC
Clin Immunol; 2010 Feb; 134(2):121-9. PubMed ID: 19837003
[TBL] [Abstract][Full Text] [Related]
12. The regulation of phenotype and function of human liver CD3+/CD56+ lymphocytes, and cells that also co-express CD8 by IL-2, IL-12 and anti-CD3 monoclonal antibody.
Jin Y; Fuller L; Carreno M; Esquenazi V; Tzakis AG; Miller J
Hum Immunol; 1998 Jun; 59(6):352-62. PubMed ID: 9634197
[TBL] [Abstract][Full Text] [Related]
13. IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin.
Clark RA; Kupper TS
Blood; 2007 Jan; 109(1):194-202. PubMed ID: 16968902
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic polyclonal human CD8+ CD25+ Fox3+ TNFR2+ PD-L1+ regulatory cells induced ex-vivo.
Horwitz DA; Pan S; Ou JN; Wang J; Chen M; Gray JD; Zheng SG
Clin Immunol; 2013 Dec; 149(3):450-63. PubMed ID: 24211847
[TBL] [Abstract][Full Text] [Related]
15. An Autocrine TNFα-Tumor Necrosis Factor Receptor 2 Loop Promotes Epigenetic Effects Inducing Human Treg Stability
Urbano PCM; Koenen HJPM; Joosten I; He X
Front Immunol; 2018; 9():573. PubMed ID: 29619032
[TBL] [Abstract][Full Text] [Related]
16. CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy.
Lim A; French MA; Price P
J Acquir Immune Defic Syndr; 2009 Jul; 51(3):248-57. PubMed ID: 19363449
[TBL] [Abstract][Full Text] [Related]
17. Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation.
Cohen AD; Schaer DA; Liu C; Li Y; Hirschhorn-Cymmerman D; Kim SC; Diab A; Rizzuto G; Duan F; Perales MA; Merghoub T; Houghton AN; Wolchok JD
PLoS One; 2010 May; 5(5):e10436. PubMed ID: 20454651
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of mouse CD4+CD25+Foxp3+ regulatory T cells in xenogeneic pig thymus-grafted nude mice suffering from autoimmune diseases.
Zhang B; Sun C; Qu Y; Zhang A; Liu J; Zhang L; Niu Z; Zhao Y
Cell Mol Immunol; 2008 Oct; 5(5):325-32. PubMed ID: 18954555
[TBL] [Abstract][Full Text] [Related]
19. Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer.
Loddenkemper C; Hoffmann C; Stanke J; Nagorsen D; Baron U; Olek S; Huehn J; Ritz JP; Stein H; Kaufmann AM; Schneider A; Cichon G
Cancer Sci; 2009 Jun; 100(6):1112-7. PubMed ID: 19514119
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T-cell expansion and function do not account for the impaired alloreactivity of ex vivo-expanded T cells.
Montcuquet N; Mercier-Letondal P; Perruche S; Duperrier A; Couturier M; Bouchekioua A; Bonyhadi M; Ferrand C; Tiberghien P; Robinet E
Immunology; 2008 Nov; 125(3):320-30. PubMed ID: 18445006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]